These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8878310)

  • 1. Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment.
    Weizman R; Laor N; Schujovitsky A; Wolmer L; Abramovitz-Schnaider P; Freudstein-Dan A; Rehavi M
    Psychiatry Res; 1996 Jul; 63(2-3):143-50. PubMed ID: 8878310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.
    Kosten TR; Frank JB; Dan E; McDougle CJ; Giller EL
    J Nerv Ment Dis; 1991 Jun; 179(6):366-70. PubMed ID: 2051152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
    Schneider LS; Munjack D; Severson JA; Palmer R
    Biol Psychiatry; 1987 Jan; 22(1):59-66. PubMed ID: 3790641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder.
    Frank JB; Kosten TR; Giller EL; Dan E
    Am J Psychiatry; 1988 Oct; 145(10):1289-91. PubMed ID: 3048121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant specificity in atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
    Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer uses for older psychotropic medications.
    Liebowitz MR
    Hosp Community Psychiatry; 1982 Apr; 33(4):282-6. PubMed ID: 6122638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets.
    Iny LJ; Pecknold J; Suranyi-Cadotte BE; Bernier B; Luthe L; Nair NP; Meaney MJ
    Biol Psychiatry; 1994 Sep; 36(5):281-91. PubMed ID: 7993954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder.
    Mavissakalian M
    Compr Psychiatry; 1983; 24(3):278-84. PubMed ID: 6347516
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet 3H-imipramine binding: a state-dependent marker in depression.
    Suranyi-Cadotte B; Quirion R; McQuade P; Nair NP; Schwartz G; Mosticyan S; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):737-41. PubMed ID: 6531445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R; Berchou R; Rainey JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J; Vallejo J
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological response to stress in agoraphobia and panic attacks.
    Surman OS; Williams J; Sheehan DV; Strom TB; Jones KJ; Coleman J
    Biol Psychiatry; 1986 Jul; 21(8-9):768-74. PubMed ID: 3524696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forms of atypical depression and their response to antidepressant drugs.
    Davidson J; Pelton S
    Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.